Stay updated with breaking news from Richards Irwin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MONDAY, Sept. 11, 2023 (HealthDay News) -- For adults with refractory or unexplained chronic cough, gefapixant leads to modest improvement in cough frequency, severity, and quality of life, according to a review published online Sept. 11 in the Journal of the American Medical Association to coincide with the European Respiratory Society International Congress 2023, held
Modest improvement seen in cough frequency, severity, and specific quality of life, but increase seen in treatment-, taste-related adverse events.
In this issue of JAMA, Kum and colleagues report the results of a high-quality systematic review and dose-response meta-analysis that evaluated the efficacy and
MONDAY, Sept. 11, 2023 (HealthDay News) -- For adults with refractory or unexplained chronic cough, gefapixant leads to modest improvement in cough frequency, severity, and quality of life, according to
Meta-analysis found mixed results for a drug that's about to go before an FDA panel